Baird analyst Brian Skorney raised the firm’s price target on Gilead (GILD) to $108 from $100 and keeps a Neutral rating on the shares. The firm updated its model following its modest beat and raise Q2 results with its Yeztugo launch in focus.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Trade Desk downgraded, Instacart upgraded: Wall Street’s top analyst calls
- Gilead price target raised to $115 from $110 at TD Cowen
- Gilead price target raised to $98 from $96 at RBC Capital
- Gilead price target raised to $128 from $125 at Oppenheimer
- Gilead price target raised to $130 from $120 at BMO Capital